Derivatives of n- [phenyl(alkylpiperidine-2-yl)methyl]benz amide, preparation method thereof and application of same in therapeutics

Details for Australian Patent Application No. 2004281216 (hide)

Owner Sanofi-Aventis

Inventors Dargazanli, Gihad; Estenne-Bouhtou, Genevieve; Veronique, Corinne

Agent Davies Collison Cave

Pub. Number AU-B-2004281216

PCT Pub. Number WO2005/037782

Priority 0312141 17.10.03 FR

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 22 July 2010

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 211/28 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037782 Priority application(s): WO2005/037782

22 July 2010 Application Accepted

  Published as AU-B-2004281216

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281217-Use of tricyclic compounds as glycine transport inhibitors

2004281215-Derivatives of N- [heteroaryl(piperidine-2-yl)methyl]benza mide, preparation method thereof and application of same in therapeutics